Scavenger receptor-AI targeted theranostic nanoparticles for regression of atherosclerotic plaques via ABCA1 modulation

Raman, 2021, Leptin in atherosclerosis: focus on macrophages, endothelial and smooth muscle cells, Int J Mol Sci, 22, 5446, 10.3390/ijms22115446 2015, Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174000 participants in 27 randomised trials, Lancet, 385, 1397, 10.1016/S0140-6736(14)61368-4 Zhang, 2023, ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease, Metabolism: clinical and experimental, 139, 10.1016/j.metabol.2022.155377 Haas, 2022, Potential therapeutic agents that target ATP binding cassette A1 (ABCA1) gene expression, Drugs, 82, 1055, 10.1007/s40265-022-01743-x Yvan-Charvet, 2010, Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses, Arterioscler Thromb Vasc Biol, 30, 139, 10.1161/ATVBAHA.108.179283 Besler, 2010, High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease, Curr Pharm Des, 16, 1480, 10.2174/138161210791051013 Chen, 2022, Molecular mechanisms for ABCA1-mediated cholesterol efflux, Cell Cycle, 21, 1121, 10.1080/15384101.2022.2042777 Pownall, 2021, High-density lipoproteins, reverse cholesterol transport and atherogenesis, Nat Rev Cardiol, 18, 712, 10.1038/s41569-021-00538-z Xu, 2021, E17241 as a novel ABCA1 (ATP-binding cassette transporter A1) upregulator ameliorates atherosclerosis in mice, Arterioscler Thromb Vasc Biol, 41, e284, 10.1161/ATVBAHA.120.314156 Matsuo, 2022, ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis, J Pharmacol Sci, 148, 197, 10.1016/j.jphs.2021.11.005 Shang, 2020, Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE-/- mice, Theranostics, 10, 10231, 10.7150/thno.48410 Segers, 2013, Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions, Arterioscler Thromb Vasc Biol, 33, 1812, 10.1161/ATVBAHA.112.300707 Wang, 2019, Scavenger receptor-AI-targeted ultrasmall gold nanoclusters facilitate in vivo MR and ex vivo fluorescence dual-modality visualization of vulnerable atherosclerotic plaques, Nanomedicine, 19, 81, 10.1016/j.nano.2019.04.003 Abdel-Maksoud, 2019, Mechanistic/mammalian target of rapamycin: recent pathological aspects and inhibitors, Med Res Rev, 39, 631, 10.1002/med.21535 Xin, 2020, Regulatory mechanisms of baicalin in cardiovascular diseases: a review, Front Pharmacol, 11, 10.3389/fphar.2020.583200 Zhu, 2021, Nanomaterials as promising theranostic tools in nanomedicine and their applications in clinical disease diagnosis and treatment, Nanomaterials, 11, 3346, 10.3390/nano11123346 Hossaini Nasr, 2021, Nanotechnology for targeted therapy of atherosclerosis, Front Pharmacol, 12, 10.3389/fphar.2021.755569 Chen, 2022, Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis, Nat Rev Cardiol, 19, 228, 10.1038/s41569-021-00629-x Qin, 2021, RACK1 T50 phosphorylation by AMPK potentiates its binding with IRF3/7 and inhibition of type 1 IFN production, J Immunol, 207, 1411, 10.4049/jimmunol.2100086 Xu, 2022, Osteopontin targeted theranostic nanoprobes for laser-induced synergistic regression of vulnerable atherosclerotic plaques, Acta Pharm Sin B, 12, 2014, 10.1016/j.apsb.2021.12.020 Öörni, 2015, Acidification of the intimal fluid: the perfect storm for atherogenesis, J Lipid Res, 56, 203, 10.1194/jlr.R050252 Zhang, 2018, Mitochondria-targeted artificial “Nano-RBCs” for amplified synergistic cancer phototherapy by a single NIR irradiation, Adv Sci, 5, 10.1002/advs.201870050 Gui, 2022, Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms, Front Cardiovasc Med, 9, 10.3389/fcvm.2022.845942 Arnao, 2019, Lipoproteins in atherosclerosis process, Curr Med Chem, 26, 1525, 10.2174/0929867326666190516103953 Orekhov, 2020, Role of phagocytosis in the pro-inflammatory response in LDL-induced foam cell formation; a transcriptome analysis, Int J Mol Sci, 21, 817, 10.3390/ijms21030817 Reiner, 2016, Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries – findings from the EUROASPIRE IV survey, Atherosclerosis, 246, 243, 10.1016/j.atherosclerosis.2016.01.018 Newman, 2019, Statin safety and associated adverse events: a scientific statement from the American Heart Association, Arterioscler Thromb Vasc Biol, 39, e38, 10.1161/ATV.0000000000000073 Nicholls, 2016, Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial, JAMA, 316, 2373, 10.1001/jama.2016.16951 Flores, 2019, Nanoparticle therapy for vascular diseases, Arterioscler Thromb Vasc Biol, 39, 635, 10.1161/ATVBAHA.118.311569 Dayar, 2022, Targeted strategy in lipid-lowering therapy, Biomedicines, 10, 1090, 10.3390/biomedicines10051090 Ma, 2021, Targeting macrophage liver X receptors by hydrogel-encapsulated T0901317 reduces atherosclerosis without effect on hepatic lipogenesis, Br J Pharmacol, 178, 1620, 10.1111/bph.15387 Ma, 2018, Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching, Theranostics, 8, 3693, 10.7150/thno.24364 Gimbrone, 2016, Endothelial cell dysfunction and the pathobiology of atherosclerosis, Circ Res, 118, 620, 10.1161/CIRCRESAHA.115.306301 Xu, 2021, Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies, Pharmacol Rev, 73, 924, 10.1124/pharmrev.120.000096 Qiao, 2020, Recent advances in molecular imaging of atherosclerotic plaques and thrombosis, Nanoscale, 12, 8040, 10.1039/D0NR00599A Chen, 2021, Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis, Adv Drug Deliv Rev, 170, 142, 10.1016/j.addr.2021.01.005 Shipunova, 2020, Dual regioselective targeting the same receptor in nanoparticle-mediated combination immuno/chemotherapy for enhanced image-guided cancer treatment, ACS Nano, 14, 12781, 10.1021/acsnano.0c03421 Di Pietro, 2016, Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis, Vascul Pharmacol, 84, 1, 10.1016/j.vph.2016.05.013 Yang, 2022, Curcumin slow-release membrane promotes erectile function and penile rehabilitation in a rat model of cavernous nerve injury, J Tissue Eng Regen Med, 16, 836, 10.1002/term.3334 Zheng, 2022, Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation, Drug Deliv, 29, 1164, 10.1080/10717544.2022.2058653 Manto, 2021, (4-Aminopyridine)-PLGA-PEG as a novel thermosensitive and locally injectable treatment for acute peripheral nerve injury, ACS Appl Bio Mater, 4, 4140, 10.1021/acsabm.0c01566 Shabani, 2022, Transplantation of bioengineered reelin-loaded PLGA/PEG micelles can accelerate neural tissue regeneration in photothrombotic stroke model of mouse, Bioeng Transl Med, 7, 10.1002/btm2.10264 Eivazi, 2020, Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody, Life Sci, 261, 10.1016/j.lfs.2020.118361 Huang, 2017, ICAM-1-targeted liposomes loaded with liver X receptor agonists suppress PDGF-induced proliferation of vascular smooth muscle cells, Nanoscale Res Lett, 12, 322, 10.1186/s11671-017-2097-6 Wang, 2014, RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer, J Control Release, 196, 222, 10.1016/j.jconrel.2014.10.012 Zhao, 2017, Fabrication of pH-responsive PLGA(UCNPs/DOX) nanocapsules with upconversion luminescence for drug delivery, Sci Rep, 7, 18014, 10.1038/s41598-017-16948-4 Fröhlich, 2012, The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles, Int J Nanomedicine, 7, 5577, 10.2147/IJN.S36111 Duan, 2021, Recent advances in drug delivery systems for targeting cancer stem cells, Acta Pharm Sin B, 11, 55, 10.1016/j.apsb.2020.09.016 Naz, 2017, PLGA-PEG nano-delivery system for epigenetic therapy, Biomed Pharmacother, 90, 586, 10.1016/j.biopha.2017.03.093 Laurent, 2021, Characterization and biodistribution of Au nanoparticles loaded in PLGA nanocarriers using an original encapsulation process, Colloids Surf B Biointerfaces, 205, 10.1016/j.colsurfb.2021.111875 Wei, 2019, TMTP1-modified indocyanine green-loaded polymeric micelles for targeted imaging of cervical cancer and metastasis sentinel lymph node in vivo, Theranostics, 9, 7325, 10.7150/thno.35346 Zaman, 2019, Current strategies in extending half-lives of therapeutic proteins, J Control Release, 301, 176, 10.1016/j.jconrel.2019.02.016 Vinod, 2014, miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages, Biochim Biophys Acta, 1841, 827, 10.1016/j.bbalip.2014.02.006 Fan, 2020, Reduced Sirtuin1 signalling exacerbates diabetic mice hindlimb ischaemia injury and inhibits the protective effect of a liver X receptor agonist, J Cell Mol Med, 24, 5476, 10.1111/jcmm.15201 Li, 2022, Opuntia dillenii Haw. Polysaccharide promotes cholesterol efflux in THP-1-derived foam cells via the PPARγ-LXRα signaling pathway, Molecules, 27, 8639, 10.3390/molecules27248639 Dong, 2019, Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR, Int J Mol Med, 43, 1927